Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

[1]  Michael J.A. Williams,et al.  The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. , 2014, Journal of the American College of Cardiology.

[2]  J. Resar,et al.  Diagnosis and Management of Valvular Aortic Stenosis , 2014, Clinical Medicine Insights. Cardiology.

[3]  A. Ribeiro,et al.  Chagas disease and mortality in old age as an emerging issue: 10 year follow-up of the Bambuí population-based cohort study (Brazil). , 2010, International journal of cardiology.

[4]  A. Hidrón,et al.  Chagas Cardiomyopathy in the Context of the Chronic Disease Transition , 2010, PLoS neglected tropical diseases.

[5]  G. Matheson,et al.  Addition of the Electrocardiogram to the Preparticipation Examination of College Athletes , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[6]  L. Cabrera,et al.  Chagas disease transmission in periurban communities of Arequipa, Peru. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  K. Gollob,et al.  Current concepts in immunoregulation and pathology of human Chagas disease , 2008, Current opinion in infectious diseases.

[8]  Federico Lombardi,et al.  Prognostic Value of Signal‐Averaged Electrocardiogram in Chagas Disease , 2008, Journal of cardiovascular electrophysiology.

[9]  Robert H Gilman,et al.  Evaluation and treatment of chagas disease in the United States: a systematic review. , 2007, JAMA.

[10]  J. C. Dias,et al.  Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. , 2007, Memorias do Instituto Oswaldo Cruz.

[11]  J. Coura.  Chagas disease: what is known and what is needed--a background article. , 2007, Memorias do Instituto Oswaldo Cruz.

[12]  B. Maciel,et al.  Pathogenesis of Chronic Chagas Heart Disease , 2007, Circulation.

[13]  A. Hasslocher-Moreno,et al.  Development and validation of a risk score for predicting death in Chagas' heart disease. , 2006, The New England journal of medicine.

[14]  A. Teixeira,et al.  Evolution and pathology in chagas disease--a review. , 2006, Memorias do Instituto Oswaldo Cruz.

[15]  S. G. Andrade,et al.  Reinfections with strains of Trypanosoma cruzi, of different biodemes as a factor of aggravation of myocarditis and myositis in mice. , 2006, Revista da Sociedade Brasileira de Medicina Tropical.

[16]  S. Laucella,et al.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure , 2004, Heart.

[17]  M. C. Nunes,et al.  Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy. , 2004, International journal of cardiology.

[18]  M. Tullu,et al.  Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. , 2003, Archives of medical research.

[19]  J. Dias,et al.  The impact of Chagas disease control in Latin America: a review. , 2002, Memorias do Instituto Oswaldo Cruz.

[20]  A. Fernández,et al.  Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage. , 2002, International journal for parasitology.

[21]  S. Barreto,et al.  Chagas' disease among older adults: branches or mainstream of the present burden of Trypanosoma cruzi infection? , 2002, International journal of epidemiology.

[22]  C. Antunes,et al.  Diagnostic electrocardiography in epidemiological studies of Chagas' disease: multicenter evaluation of a standardized method. , 1998, Revista panamericana de salud publica = Pan American journal of public health.

[23]  R. Bestetti,et al.  Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study. , 1996, Cardiology.

[24]  P. Kozarsky,et al.  The epidemiology of Chagas' disease in a hyperendemic area of Cochabamba, Bolivia: a clinical study including electrocardiography, seroreactivity to Trypanosoma cruzi, xenodiagnosis, and domiciliary triatomine distribution. , 1992, The American journal of tropical medicine and hygiene.

[25]  M. Rossi,et al.  Chronic chagasic myocarditis pathogenesis: dependence on autoimmune and microvascular factors. , 1992, American heart journal.

[26]  Control of Chagas' disease , 1992, The Lancet.

[27]  M. Rossi.  Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. , 1990, American heart journal.

[28]  H. Carrasco,et al.  [Clinical and paraclinical differences between chronic Chagas' cardiomyopathy and primary dilated cardiomyopathies]. , 1989, Arquivos brasileiros de cardiologia.

[29]  T. Weinke,et al.  Cardiac morbidity due to Chagas' disease in a rural community in Bolivia , 1988, Epidemiology and Infection.

[30]  H Acquatella,et al.  Long-term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. , 1987, Circulation.

[31]  J. Maguire,et al.  Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. , 1987, Circulation.

[32]  R. Isturiz,et al.  Chagas Disease , 2021, Neglected Tropical Diseases.

[33]  R. Morrow,et al.  Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil. , 1983, American heart journal.

[34]  A. Ribeiro,et al.  Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[35]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.